American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • Stories
  • »
  • American Pharmacy News Reports

URAC awards Specialty Pharmacy accreditation to CVS Specialty

American Pharmacy News Reports | Apr 5, 2016
CVS Specialty was awarded Specialty Pharmacy accreditation by the URAC

CVS Health has announced that its specialty pharmacy, CVS Specialty, has been awarded Specialty Pharmacy accreditation from URAC. Read More »

MHLW approves GSK’s Nucala in Japan

American Pharmacy News Reports | Apr 5, 2016
The MHLW approved Nacula based on data from mepolizumab studies

GlaxoSmithKline (GSK) has announced the approval of Nucala (mepolizumab) by the Japanese Ministry of Health Labor and Welfare (MHLW). Read More »

Rich Pharmaceuticals contracts oncology clinical study to CMIC ASIA-PACIFIC

American Pharmacy News Reports | Apr 5, 2016

Rich Pharmaceuticals Inc. announced this week that CMIC ASIA-PACIFIC PTD. LTD., an Asian contract research organization (CRO), will run the first phase of an upcoming oncology clinical. Read More »

New policies announced by APhA House of Delegates

American Pharmacy News Reports | Apr 4, 2016
The APhA House of Delegates voted on the new policies at the APhA Annual Meeting and Exposition 2016

The APhA (American Pharmacists Association) House of Delegates has published the report detailing the polices that were adopted at the APhA Annual Meeting and Exposition (APhA 2016) in Baltimore, Maryland. Read More »

ASHP’s annual midyear meeting wins multiple awards

American Pharmacy News Reports | Apr 4, 2016
The ASHP's Midyear Clinical Meeting won multiple trade show awards

The American Society of Health-System Pharmacists’ (ASHP) Midyear Clinical Meeting and Exhibition was recently honored with three awards. Read More »

BCBSIL and ICS announce oncology Intensive Medical Home program

American Pharmacy News Reports | Apr 4, 2016
BCBSIL and ICS have announced the first oncology Intensive Medical Home program to treat patients

Blue Cross and Blue Shield of Illinois (BCBSIL) and Illinois Cancer Specialists (ICS) have announced the very first oncology intensive medical home (IMH) pilot program in Illinois. Read More »

Amgen and UCB release positive data from Phase 3 romosozumab trial

American Pharmacy News Reports | Apr 4, 2016
Amgen and UCB have released data from the Phase 3 romosozumab trial

Amgen and UCB have announced the results of the Phase 3 trial for romosozumab. Read More »

Washington attorney comments on skyrocketing prescription drug costs

American Pharmacy News Reports | Apr 2, 2016
William Schiffbauer, a Washington attorney, has weighed in on skyrocketing prescription drug costs.

In the wake of recent scandals involving drug manufacturers such as Valeant, renewed attention has been drawn to the skyrocketing cost of prescription drugs and the attendant problem of rising health insurance costs across the U.S. Read More »

FDA grants Actinium’s Iomab-B orphan drug designation

American Pharmacy News Reports | Apr 1, 2016
The FDA has granted Actinium's Iomab-B orphan drug designation

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Iomab-B, a radioimmunotherapeutic developed by Actinium Pharmaceuticals that is designed to aid patients with reverted and stubborn Acute Myeloid Leukemia (AML) so they can receive a Hematopoietic Stem Cell Transplant (HSCT). Read More »

Oasmia enrolls first patient into Phase 1 Docecal trial

American Pharmacy News Reports | Apr 1, 2016
Oasmia has enrolled the first patient to take part in its Phase 1 trial for Docecal

Oasmia Pharmaceuticals, which develops innovative drugs within human and veterinary oncology, has announced that the first patient to take part in the Phase 1 clinical trial for Docecal, the company’s groundbreaking cancer treatment, has been enrolled. Read More »

Actinium names Jennifer Liberi Director of Clinical Operations

American Pharmacy News Reports | Apr 1, 2016
Actinium has named Jennifer Liberi the new Director of Clinical Operations

Actinium Pharmaceuticals has announced that it has named Jennifer Liberi Director of Clinical Operations. Read More »

UsAgainstAlzheimer’s confident in new line of Alzheimer’s drugs

American Pharmacy News Reports | Apr 1, 2016
Seventeen new drugs to treat Alzheimer's are currently being produced

Recent research conducted by ResearchersAgainstAlzheimer’s (RA2), an UsAgainstAlzheimer’s (UsA2) network, reports 17 new drugs aimed at treating Alzheimer’s will be developed in the next five years. Read More »

Eisai and Ajinomoto announce newly formed EA Pharma

American Pharmacy News Reports | Mar 31, 2016
Eisai and Ajinomoto have announced the formation of EA Pharm

Eisai Co. Ltd. and Ajinomoto Co. Inc. have announced the establishment of EA Pharma Co. Ltd., based on the integration agreement signed by both companies on October 15 of last year. Read More »

PBM acquires AkaRx, avatrombopag from Eisai Inc.

American Pharmacy News Reports | Mar 31, 2016
PBM and Eisai have entered into an agreement to tranfer all shares of AkaRx to PBM

Eisai Co. Ltd. has announced that Eisai Inc., the company’s subsidiary located in the United States, has entered into a shared purchase agreement that will transfer all of Eisai Inc.’s shares of AkaRx Inc. to PBM Capital Group LLC. Read More »

Pfizer and Bristol-Myers Squibb to present Eliquis data at ACC.16

American Pharmacy News Reports | Mar 31, 2016
Pfizer and Bristol-Myers Squibb have released the 17 abstracts that will be presented at the ACC.16

Pfizer and Bristol-Myers Squibb have released the 17 abstracts that the two companies will present at the American College of Cardiology’s 65th Annual Scientific Session (ACC.16) in Chicago on April 2-4. Read More »

Sanofi and Regeneron to present Praluent data at ACC.16

American Pharmacy News Reports | Mar 31, 2016
Sanofi and Regeneron will present Praluent data at ACC.16

Sanofi and Regeneron Pharmaceuticals will be presenting new joint Phase 3 data from the clinical trial for the Praluent (alirocumab) Injection at the American College of Cardiology’s 65th Annual Scientific Session & Expo (ACC.16) in Chicago on April 2-4. Read More »

FDA approves Teva’s CINQAIR Injection for asthma treatment

American Pharmacy News Reports | Mar 30, 2016
The FDA has approved Teva's CINQAIR for the treatment of asthma

Teva Pharmaceutical Industries has announced that the U.S. Food and Drug Administration (FDA) has approved its interleukin 5 antagonist monoclonal antibody (lgG4 kappa), CINQAIR (reslizumab) Injection. Read More »

UnitedHealthcare celebrates opening of new Davenport office

American Pharmacy News Reports | Mar 30, 2016
UnitedHealthcare celebrated the opening of its new Davenport office

UnitedHealthcare celebrated the opening of its new office in Davenport, Iowa last week and the expansion of its headquarters located in West Des Moines. Read More »

Walgreens returning as partner for second annual Red Nose Day

American Pharmacy News Reports | Mar 30, 2016
Walgreens has announced that it will return as an exclusive retail partner for the second annual Red Nose Day

Walgreens has confirmed that it will be returning as the second annual Red Nose Day’s exclusive retail partner on May 26. Read More »

UnitedHealthcare Community of Louisiana awards $3.4 million to statewide practices

American Pharmacy News Reports | Mar 30, 2016
UnitedHealthcare Community of Louisiana has awarded $3.4 million to practices across Louisiana

UnitedHealthcare Community Plan of Louisiana announced this week that it has awarded more than $3.4 million to 249 physician practices across the state as bonus payments for improving the quality of care for patients who are enrolled in UnitedHealthcare’s Medicaid plans. Read More »

  • «
  • 1
  • 2
  • ...
  • 105
  • 106
  • 107 (current)
  • 108
  • 109
  • ...
  • 168
  • 169
  • »
Trending

Scott Newman, Chairman, Pharmacists United for Truth and Transparency

Pharmacists United for Truth and Transparency: PBMs are the ‘primary driver of high drug prices in the U.S.’

Dr. Gerard Acloque, Doctor for Florida Concierge Medicine & Wellness

Doctor on Eli Lilly compounding pharmacy lawsuit: 'We are now left with very little options outside the branded medications'

Sazan Sylejmani, Owner & Pharmacy Manager of Westmont Pharmacy

Monty's Home Medical highlights benefits of tailored compounded medications

Craig Brockie, Founder & CEO of Ultimate Health Solutions

Ultimate Health Solutions founder on Patients First: 'Our healthcare system doesn't reward health'

 Jeff Harrell Board President

NCPA comments on Trump's executive order concerning drug pricing

Copyright © 2025 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up